Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lidocaine Infusion in Laparoscopic Cholecystectomy
NCT06740903Phase 3Recruiting
- Sponsor
- Sahiwal Medical College
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, hemodynamic instability, Digestive tract dysfunction, sponsored by Sahiwal Medical College. Started Aug 2024; status: recruiting.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painhemodynamic instabilityDigestive tract dysfunction
Beyond the preview
Go deeper on NCT06740903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06740903.